Haduvio

nalbuphine extended-release · Trevi Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Haduvio, covering 2025-06-24 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Refractory Chronic Cough Improvement Via NAL ER (RIVER) [Phase 2]